We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Chong Han - Principal Scientist (Chemistry), Small Molecule Pharmaceutical Sciences: Process Chemistry

Chong Han

Principal Scientist (Chemistry), Small Molecule Pharmaceutical Sciences: Process Chemistry

"I am driven by finding practical solutions to challenging chemical problems that could eventually make a difference in patient’s lives."
12
Years at Genentech
18
Publications at Genentech
4
Awards & Honors

I joined the small molecule process chemistry group in 2010 after a postdoctoral stint with Prof. Stephen Buchwald at MIT. My current role includes leading team efforts developing efficient and robust chemical processes to supply the active pharmaceutical ingredient (API) for clinical studies and building internal technology platforms in the area of high-throughput experimentation (HTE), transition-metal catalysis, and continuous flow chemistry.

Featured Publication

Asymmetric Synthesis of Akt Kinase Inhibitor Ipatasertib

Org. Lett. 2017, 19, 4806–4809.

Han, C.; Savage, S.; Al-Sayah, M.; Yajiama, H.; Remarchuk, T.; Reents, R.; Wirz, B.; Iding, H.; Bachmann, S.; Fantasia, S.; Scalone, M.; Hell, A.; Hidber, P.; Gosselin, F.*